Abzena PLC’s (ABZA) Buy Rating Reiterated at Numis Securities Ltd
Numis Securities Ltd reissued their buy rating on shares of Abzena PLC (LON:ABZA) in a research report released on Thursday morning. Numis Securities Ltd currently has a GBX 80 ($1.03) target price on the stock.
Separately, FinnCap restated a buy rating and issued a GBX 80 ($1.03) price objective on shares of Abzena PLC in a research report on Wednesday, June 14th.
Shares of Abzena PLC (LON ABZA) opened at 34.00 on Thursday. The company’s market cap is GBX 46.87 million. The stock’s 50 day moving average is GBX 45.41 and its 200 day moving average is GBX 41.25. Abzena PLC has a 52-week low of GBX 31.00 and a 52-week high of GBX 66.00.
About Abzena PLC
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with MarketBeat.com's FREE daily email newsletter.